SAB-402

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameSAB-402
Drug Alias NameSAB-402
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-4 antagonistsEGFR T790M inhibitors
TargetsReceptor protein-tyrosine kinase erbB-4EGFR T790M
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSabila Biosciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesSabila Biosciences LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A